Frédéric Lavie
Affiliations: | Université Paris Diderot - Paris 7, Paris, Île-de-France, France |
Google:
"Frédéric Lavie"Parents
Sign in to add mentor| Xavier Mariette | grad student | 2006 | Université Paris 7 | |
| (Etude de l'implication de la cytokine BAFF dans le développement des maladies auto-immunes : application au syndrome de Sjögren) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lavie MC, Feydy A, Gossec L, et al. (2009) Valeur diagnostique de l’IRM et de l’echographie-doppler puissance des talons au cours de la spondylarthropathie Journal De Radiologie. 90: 1325 |
| Sellam J, Miceli-Richard C, Gottenberg JE, et al. (2008) Is Inhibitor of differentiation 3 involved in human primary Sjögren's syndrome? Rheumatology (Oxford, England). 47: 437-41 |
| Lavie F, Miceli-Richard C, Ittah M, et al. (2008) B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome. Scandinavian Journal of Immunology. 67: 185-92 |
| Pavy S, Dernis E, Lavie F, et al. (2007) Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 338-45 |
| Lavie F, Pavy S, Dernis E, et al. (2007) Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 346-52 |
| Dernis E, Lavie F, Pavy S, et al. (2007) Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint, Bone, Spine : Revue Du Rhumatisme. 74: 330-7 |
| Terrier B, Ittah M, Tourneur L, et al. (2007) Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery. Haematologica. 92: e20-3 |
| Sellam J, Miceli-Richard C, Gottenberg JE, et al. (2007) Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus. Annals of the Rheumatic Diseases. 66: 790-7 |
| Lavie F, Miceli-Richard C, Ittah M, et al. (2007) Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production. Annals of the Rheumatic Diseases. 66: 700-3 |
| Dernis E, Lavie F, Salliot C, et al. (2007) Les traitements médicamenteux (hors biothérapie) dans la prise en charge de patients atteints de rhumatisme psoriasique périphérique : élaboration de recommandations pour la pratique clinique, à partir d’une analyse systématique de la littérature et de l’opinion d’experts Revue Du Rhumatisme. 74: 31-38 |